When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn up 10% on completion of leronlimab application for HIV
CytoDyn Inc
CytoDyn (OTCQB:CYDY+10.1%) has completed the rolling submission of its U.S. marketing application seeking approval to use leronlimab, combined with highly active antiretroviral therapy (HAART), in treatment-experienced HIV patients, a Fast Track-tagged indication.
More news on: CytoDyn Inc., Healthcare stocks news, Stocks on the move,